Eficacia, efectividad y eficiencia de la vacunación antineumocócica en las personas de 65 años o mayores
- 1 January 2000
- Vol. 1 (2) , 75-79
- https://doi.org/10.1016/s1576-9887(00)70195-6
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- The clinical effectiveness of pneumococcal vaccination:Vaccine, 1999
- Clinical Efficacy of Pneumococcal Vaccine in the ElderlyThe American Journal of Medicine, 1997
- Five‐Hundred Life‐Saving Interventions and Their Cost‐EffectivenessRisk Analysis, 1995
- Pneumococcal Vaccination: Work to Date and Future ProspectsThe Lancet Healthy Longevity, 1990
- Efficacy of Pneumococcal Vaccine in High-Risk PatientsNew England Journal of Medicine, 1986
- Resolving the Pneumococcal Vaccine Controversy: Are There Alternatives to Randomized Clinical Trials?Clinical Infectious Diseases, 1984
- Efficacy of Pneumococcal Polysaccharide VaccinesClinical Infectious Diseases, 1981
- Cost Effectiveness of Vaccination against Pneumococcal PneumoniaNew England Journal of Medicine, 1980
- Impaired Antibody Response to Pneumococcal Vaccine after Treatment for Hodgkin's DiseaseNew England Journal of Medicine, 1978
- Antibody Response to Capsular Polysaccharide Vaccine of Streptococcus pneumoniae in Patients with Nephrotic SyndromeThe Journal of Infectious Diseases, 1978